comparemela.com

Page 8 - Pastric News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Novel RNA Releasing Pill

RNA releasing pill in the stomach could offer a new way to administer vaccines, or to deliver therapies for gastrointestinal disease.

United statesMassachusetts instituteNa releasing pillGastrointestinal disease

Cancer Advances Inc: Cancer Advances, Inc Announces Abstract and Poster Presentation at ASCO GI - Role of an anti-gastrin vaccine (PAS) in combination with a PD-1 antibody on growth and metastasis of gastric cancer

DURHAM, N.C., Jan. 19, 2022 (GLOBE NEWSWIRE) Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers, will host a virtual presentation

United statesSan franciscoJillp smithKostenloser wertpapierhandelAmerican society of clinical oncologyGeorgetown university medical centerCancer advances incAmerican societyClinical oncologyGastrointestinal cancers symposiumMoscone west buildingCancer advance polyclonal antibody stimulatorRelated publicationCancer advancesPolyclonal antibody stimulatorAntibody stimulator

Pieris Pharmaceuticals, Inc : Pieris Pharmaceuticals Announces Dosing of First Patient in Phase 2 Gastric Cancer Trial of 4-1BB/HER2 Bispecific Cinrebafusp Alfa

BOSTON, MA / ACCESSWIRE / January 14, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology

United statesMaria kelmanTim demuthDrug administrationPieris pharmaceuticalsCompany quarterly reports on formExchange commissionCompany annual report on formSecurities exchangePieris pharmaceuticals incChief medical officerCinrebafusp alfaLooking statementsSecurities actSecurities exchange actAnnual report

Study finds protein variant that renders chemotherapy ineffective in gastric cancer

A study by a multidisciplinary team at Weill Cornell Medicine has identified a new protein variant that underlies the ability of gastric cancers to resist an otherwise effective family of chemotherapy drugs.

Olivier elementoManish shahParaskevi giannakakouIsrael englander institute for precision medicineSolid tumor oncology servicePresbyterian weill cornell medical centerMeyer cancer center at weill cornell medicineGastrointestinal oncology programDivision of hematologyWeill cornell medicineMedical oncologyEdward meyer cancer centerWeill cornellWeill cornell medical centerBartlett family professorGastrointestinal oncology

Cancer Advances Inc: Cancer Advances, Inc Announces Publication, Gastrin Vaccine Alone and in Combination with an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer in Frontiers in Oncology

DURHAM, N.C., Dec. 06, 2021 (GLOBE NEWSWIRE) Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers, announces a new publication in Frontiers

Jillp smithKostenloser wertpapierhandelGeorgetown university medical centerCancer advances incGastrointestinal cancersPolyclonal antibody stimulatorCancer advancesAntibody stimulator

vimarsana © 2020. All Rights Reserved.